Novo Nordisk has requested the FDA to block manufacture of compounded copies of copyright, arguing that it’s far too difficult to do safely. It’s the latest escalation in a brewing war among pharmaceutical firms and compounders.Investigators haven't discovered a culprit while in the health problems described in dozens of states. But officials s